|
PNO1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.04759999999915E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.231120E-04 |
| Normal-vs-Stage2 |
2.176000E-02 |
| Normal-vs-Stage3 |
6.03270000000267E-05 |
| Normal-vs-Stage4 |
1.88262999999411E-05 |
| Stage1-vs-Stage2 |
7.133600E-01 |
| Stage1-vs-Stage3 |
2.818800E-01 |
| Stage1-vs-Stage4 |
6.448000E-02 |
| Stage2-vs-Stage3 |
3.160000E-01 |
| Stage2-vs-Stage4 |
1.036590E-01 |
| Stage3-vs-Stage4 |
3.412200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.99678999999175E-05 |
| Normal-vs-AfricanAmerican |
1.201810E-01 |
| Normal-vs-Asian |
4.582400E-03 |
| Caucasian-vs-AfricanAmerican |
3.057600E-01 |
| Caucasian-vs-Asian |
9.680800E-01 |
| AfricanAmerican-vs-Asian |
4.405200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.34659999995179E-06 |
| Normal-vs-Female |
2.046600E-04 |
| Male-vs-Female |
1.592420E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.376000E-04 |
| Normal-vs-Age(41-60Yrs) |
2.96170000002594E-06 |
| Normal-vs-Age(61-80Yrs) |
3.777300E-04 |
| Normal-vs-Age(81-100Yrs) |
4.877400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.081560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.047600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.424200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.832800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.870420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.037400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.754020E-01 |
| Classical-VS-Follicular |
3.564400E-01 |
| Classical-VS-Other |
4.739700E-02 |
| Classical-VS-Normal |
1.659040E-03 |
| Tall-VS-Follicular |
6.172600E-01 |
| Tall-VS-Other |
2.218600E-01 |
| Tall-VS-Normal |
1.283880E-03 |
| Follicular-VS-Other |
1.982780E-01 |
| Follicular-VS-Normal |
1.084830E-03 |
| Other-VS-Normal |
5.798000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.442140E-04 |
| Normal-vs-N1 |
6.23539999999867E-05 |
| N0-vs-N1 |
1.649370E-01 |
|
|
